Rekah Pharmaceutical Industry Ltd Free Cash Flow Generation Index
Rekah Pharmaceutical Industry Ltd free cash flow generation index. Rekah Pharmaceutical Industry Ltd (REKA) has a Free Cash Flow Generation Index of 0.96x as of June 2026. Free cash flow of ILA13.32 Million represents 1% of operating cash flow (ILA13.82 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Rekah Pharmaceutical Industry Ltd (2002–2025)
Free cash flow generation index of Rekah Pharmaceutical Industry Ltd from 2002 to 2025. Historical FCF Generation Index trend for Rekah Pharmaceutical Industry Ltd across 21 annual periods. See Rekah Pharmaceutical Industry Ltd (REKA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Rekah Pharmaceutical Industry Ltd Free Cash Flow Generation Index by Year (2002–2025)
Rekah Pharmaceutical Industry Ltd free cash flow generation index by year from 2002 to 2025. Year-by-year Free Cash Flow Generation Index for Rekah Pharmaceutical Industry Ltd. For the full cash flow conversion analysis, see Rekah Pharmaceutical Industry Ltd cash conversion from operations.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | ILA5.92 Million | ILA12.95 Million | ILA7.03 Million | ▼ -32.0% |
| 2024 | 0.67x | ILA17.84 Million | ILA26.54 Million | ILA8.70 Million | ▲ +13.0% |
| 2023 | 0.59x | ILA16.86 Million | ILA28.35 Million | ILA11.49 Million | ▼ -26.4% |
| 2022 | 0.81x | ILA31.52 Million | ILA39.00 Million | ILA7.48 Million | ▲ +138.4% |
| 2021 | 0.34x | ILA7.17 Million | ILA21.17 Million | ILA13.99 Million | ▲ +150.6% |
| 2020 | -0.67x | ILA-7.55 Million | ILA11.28 Million | ILA18.84 Million | ▼ -97.6% |
| 2019 | -0.34x | ILA-11.48 Million | ILA33.91 Million | ILA45.40 Million | ▼ -377.7% |
| 2018 | 0.12x | ILA2.11 Million | ILA17.28 Million | ILA15.18 Million | ▼ -60.3% |
| 2017 | 0.31x | ILA7.32 Million | ILA23.80 Million | ILA16.48 Million | ▼ -25.2% |
| 2016 | 0.41x | ILA9.38 Million | ILA22.82 Million | ILA13.44 Million | ▲ +132.5% |
| 2015 | -1.26x | ILA-7.34 Million | ILA5.81 Million | ILA13.15 Million | ▲ +90.6% |
| 2014 | -13.49x | ILA-17.94 Million | ILA1.33 Million | ILA19.27 Million | ▼ -2256.8% |
| 2013 | 0.63x | ILA7.32 Million | ILA11.71 Million | ILA4.38 Million | ▲ +103.3% |
| 2012 | 0.31x | ILA4.36 Million | ILA14.18 Million | ILA9.82 Million | ▼ -85.8% |
| 2010 | 2.17x | ILA14.61 Million | ILA6.73 Million | ILA7.87 Million | ▲ +59.7% |
| 2009 | 1.36x | ILA35.36 Million | ILA26.03 Million | ILA9.33 Million | ▼ -48.4% |
| 2008 | 2.63x | ILA17.30 Million | ILA6.57 Million | ILA10.73 Million | ▲ +84.9% |
| 2007 | 1.42x | ILA17.73 Million | ILA12.45 Million | ILA5.28 Million | ▼ -46.4% |
| 2005 | 2.66x | ILA11.36 Million | ILA4.27 Million | ILA7.09 Million | ▲ +110.5% |
| 2004 | 1.26x | ILA22.57 Million | ILA17.87 Million | ILA4.70 Million | ▲ +3.7% |
| 2002 | 1.22x | ILA13.64 Million | ILA11.21 Million | ILA2.44 Million | — |